首页 > 最新文献

Current Opinion in Chemical Biology最新文献

英文 中文
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential 以 Nav1.8 为靶点的药物发现:结构见解和治疗潜力
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-17 DOI: 10.1016/j.cbpa.2024.102538
Huan Wang , Jian Huang , Jie Zang , Xueqin Jin , Nieng Yan
Voltage-gated sodium (Nav) channels are crucial in transmitting action potentials in neurons. The tetrodotoxin-resistant subtype Nav1.8 is predominantly expressed in the peripheral nervous system, offering a unique opportunity to design selective inhibitors for pain relief. A number of compounds have been reported to specifically block Nav1.8. Among these, VX-548 is already in regulatory review for the treatment of moderate-to-severe acute pain and holds the promise to be the first non-opioid pain killer over the past twenty years. Recent structural studies using cryogenic electron microscopy (cryo-EM) and structure-based predictive modeling have provided unprecedented insights into the structural pharmacology of Nav1.8. In this review, we summarize the latest developments in Nav1.8-selective inhibitors, focusing on the druggable sites and mechanisms that confer subtype specificity. These structural insights highlight the potential for Nav1.8 inhibitors to deliver non-addictive pain management, thus illuminating the avenue to next-generation analgesic development.
电压门控钠(Nav)通道是神经元传递动作电位的关键。耐河豚毒素亚型 Nav1.8 主要在外周神经系统中表达,这为设计用于缓解疼痛的选择性抑制剂提供了独特的机会。据报道,许多化合物都能特异性阻断 Nav1.8。其中,VX-548 已进入监管审查阶段,用于治疗中度至重度急性疼痛,有望成为过去二十年来首个非阿片类止痛药。最近利用低温电子显微镜(cryo-EM)和基于结构的预测模型进行的结构研究为 Nav1.8 的结构药理学提供了前所未有的见解。在这篇综述中,我们总结了 Nav1.8 选择性抑制剂的最新进展,重点介绍了赋予亚型特异性的可药用位点和机制。这些结构性见解凸显了 Nav1.8 抑制剂提供非成瘾性疼痛治疗的潜力,从而为下一代镇痛药的开发指明了道路。
{"title":"Drug discovery targeting Nav1.8: Structural insights and therapeutic potential","authors":"Huan Wang ,&nbsp;Jian Huang ,&nbsp;Jie Zang ,&nbsp;Xueqin Jin ,&nbsp;Nieng Yan","doi":"10.1016/j.cbpa.2024.102538","DOIUrl":"10.1016/j.cbpa.2024.102538","url":null,"abstract":"<div><div>Voltage-gated sodium (Na<sub>v</sub>) channels are crucial in transmitting action potentials in neurons. The tetrodotoxin-resistant subtype Na<sub>v</sub>1.8 is predominantly expressed in the peripheral nervous system, offering a unique opportunity to design selective inhibitors for pain relief. A number of compounds have been reported to specifically block Na<sub>v</sub>1.8. Among these, VX-548 is already in regulatory review for the treatment of moderate-to-severe acute pain and holds the promise to be the first non-opioid pain killer over the past twenty years. Recent structural studies using cryogenic electron microscopy (cryo-EM) and structure-based predictive modeling have provided unprecedented insights into the structural pharmacology of Na<sub>v</sub>1.8. In this review, we summarize the latest developments in Na<sub>v</sub>1.8-selective inhibitors, focusing on the druggable sites and mechanisms that confer subtype specificity. These structural insights highlight the potential for Na<sub>v</sub>1.8 inhibitors to deliver non-addictive pain management, thus illuminating the avenue to next-generation analgesic development.</div></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"83 ","pages":"Article 102538"},"PeriodicalIF":6.9,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142445250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond chloroquine: Cationic amphiphilic drugs as endosomal escape enhancers for nucleic acid therapeutics 超越氯喹:阳离子两亲药物作为核酸治疗药物的内体逸出增强剂。
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-05 DOI: 10.1016/j.cbpa.2024.102531
Aliona Debisschop , Bram Bogaert , Cristina Muntean , Stefaan C. De Smedt , Koen Raemdonck
Nucleic acid (NA) therapeutics have the potential to treat or prevent a myriad of diseases but generally require cytosolic delivery to be functional. NA drugs are therefore often encapsulated into delivery systems that mediate effective endocytic uptake by target cells, but unfortunately often display limited endosomal escape efficiency. This review will focus on the potential of repurposing cationic amphiphilic drugs (CADs) to enhance endosomal escape. In general terms, CADs are small molecules with one or more hydrophobic groups and a polar domain containing a basic amine. CADs have been reported to accumulate in acidified intracellular compartments (e.g., endosomes and lysosomes), integrate in cellular membranes and alter endosomal trafficking pathways, ultimately resulting in improved cytosolic release of the endocytosed cargo. As many CADs are widely used drugs, their repurposing offers opportunities for combination therapies with NAs.
核酸(NA)疗法有可能治疗或预防多种疾病,但通常需要通过胞吐传递才能发挥作用。因此,核酸药物通常被封装在递送系统中,以促进靶细胞的有效内吞,但不幸的是,内吞效率往往有限。本综述将重点探讨阳离子两亲药物(CADs)的再利用潜力,以提高内泌体转运能力。一般来说,CADs 是具有一个或多个疏水基团和一个含有碱性胺的极性域的小分子。据报道,CADs 可在酸化的细胞内区室(如内体和溶酶体)中积聚,整合到细胞膜中,并改变内体转运途径,最终改善内吞货物的胞浆释放。由于许多 CADs 都是广泛使用的药物,因此它们的再利用为与 NAs 的联合疗法提供了机会。
{"title":"Beyond chloroquine: Cationic amphiphilic drugs as endosomal escape enhancers for nucleic acid therapeutics","authors":"Aliona Debisschop ,&nbsp;Bram Bogaert ,&nbsp;Cristina Muntean ,&nbsp;Stefaan C. De Smedt ,&nbsp;Koen Raemdonck","doi":"10.1016/j.cbpa.2024.102531","DOIUrl":"10.1016/j.cbpa.2024.102531","url":null,"abstract":"<div><div>Nucleic acid (NA) therapeutics have the potential to treat or prevent a myriad of diseases but generally require cytosolic delivery to be functional. NA drugs are therefore often encapsulated into delivery systems that mediate effective endocytic uptake by target cells, but unfortunately often display limited endosomal escape efficiency. This review will focus on the potential of repurposing cationic amphiphilic drugs (CADs) to enhance endosomal escape. In general terms, CADs are small molecules with one or more hydrophobic groups and a polar domain containing a basic amine. CADs have been reported to accumulate in acidified intracellular compartments (e.g., endosomes and lysosomes), integrate in cellular membranes and alter endosomal trafficking pathways, ultimately resulting in improved cytosolic release of the endocytosed cargo. As many CADs are widely used drugs, their repurposing offers opportunities for combination therapies with NAs.</div></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"83 ","pages":"Article 102531"},"PeriodicalIF":6.9,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142379705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catalyzing the future: recent advances in chemical synthesis using enzymes 催化未来:利用酶进行化学合成的最新进展。
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-05 DOI: 10.1016/j.cbpa.2024.102536
Julia C. Reisenbauer , Kathleen M. Sicinski , Frances H. Arnold
Biocatalysis has the potential to address the need for more sustainable organic synthesis routes. Protein engineering can tune enzymes to perform in cascade reactions and for efficient synthesis of enantiomerically enriched compounds, using both natural and new-to-nature reaction pathways. This review highlights recent achievements in biocatalysis, especially the development of novel enzymatic syntheses to access versatile small molecule intermediates and complex biomolecules. Biocatalytic strategies for the degradation of persistent pollutants and approaches for biomass valorization are also discussed. The transition of chemical synthesis to a greener future will be accelerated by implementing enzymes and engineering them for high performance and new activities.
生物催化有可能满足对更具可持续性的有机合成途径的需求。蛋白质工程可以调整酶,使其在级联反应中发挥作用,并利用天然反应途径和新自然反应途径高效合成对映体丰富的化合物。本综述重点介绍生物催化领域的最新成就,特别是开发新型酶合成技术,以获得多功能小分子中间体和复杂生物大分子。此外,还讨论了降解持久性污染物的生物催化策略和生物质增值的方法。通过使用酶和对酶进行高性能和新活动的工程设计,将加速化学合成向更绿色的未来过渡。
{"title":"Catalyzing the future: recent advances in chemical synthesis using enzymes","authors":"Julia C. Reisenbauer ,&nbsp;Kathleen M. Sicinski ,&nbsp;Frances H. Arnold","doi":"10.1016/j.cbpa.2024.102536","DOIUrl":"10.1016/j.cbpa.2024.102536","url":null,"abstract":"<div><div>Biocatalysis has the potential to address the need for more sustainable organic synthesis routes. Protein engineering can tune enzymes to perform in cascade reactions and for efficient synthesis of enantiomerically enriched compounds, using both natural and new-to-nature reaction pathways. This review highlights recent achievements in biocatalysis, especially the development of novel enzymatic syntheses to access versatile small molecule intermediates and complex biomolecules. Biocatalytic strategies for the degradation of persistent pollutants and approaches for biomass valorization are also discussed. The transition of chemical synthesis to a greener future will be accelerated by implementing enzymes and engineering them for high performance and new activities.</div></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"83 ","pages":"Article 102536"},"PeriodicalIF":6.9,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142379706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in the expanding genetic code 扩展遗传密码的最新进展。
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-10-03 DOI: 10.1016/j.cbpa.2024.102537
Michael L. Pigula, Peter G. Schultz
For over a billion years, the central dogma of biology has been limited largely to 20 canonical amino acids with relatively simple functionalities. The ability to rationally add new building blocks to the genetic code has enabled the site-specific incorporation of hundreds of noncanonical amino acids (ncAAs) with novel properties into proteins in living organisms. Recent technological advances have enabled high level mammalian expression of proteins containing ncAAs, the use of unique codons to direct ncAA incorporation, extension of this methodology to a range of eukaryotic organisms, and the ability to encode building blocks beyond α-amino acids. These ncAAs have been used to study and control proteins in their native cellular context and to engineer enzymes and biotherapeutics with improved or novel properties. Herein we discuss recent developments in the field and potential future research directions.
十多亿年来,生物学的核心教条一直局限于 20 个功能相对简单的典型氨基酸。在遗传密码中合理添加新构建模块的能力,使数百种具有新特性的非规范氨基酸(ncAAs)能够特异性地加入生物体的蛋白质中。最近的技术进步实现了含有 ncAAs 的蛋白质在哺乳动物体内的高水平表达,使用独特的密码子指导 ncAAs 的结合,将这种方法推广到一系列真核生物体,并能够编码 α 氨基酸以外的构建模块。这些 ncAAs 已被用于研究和控制原生细胞环境中的蛋白质,以及设计具有改进或新特性的酶和生物治疗药物。在此,我们将讨论该领域的最新进展以及未来潜在的研究方向。
{"title":"Recent advances in the expanding genetic code","authors":"Michael L. Pigula,&nbsp;Peter G. Schultz","doi":"10.1016/j.cbpa.2024.102537","DOIUrl":"10.1016/j.cbpa.2024.102537","url":null,"abstract":"<div><div>For over a billion years, the central dogma of biology has been limited largely to 20 canonical amino acids with relatively simple functionalities. The ability to rationally add new building blocks to the genetic code has enabled the site-specific incorporation of hundreds of noncanonical amino acids (ncAAs) with novel properties into proteins in living organisms. Recent technological advances have enabled high level mammalian expression of proteins containing ncAAs, the use of unique codons to direct ncAA incorporation, extension of this methodology to a range of eukaryotic organisms, and the ability to encode building blocks beyond α-amino acids. These ncAAs have been used to study and control proteins in their native cellular context and to engineer enzymes and biotherapeutics with improved or novel properties. Herein we discuss recent developments in the field and potential future research directions.</div></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"83 ","pages":"Article 102537"},"PeriodicalIF":6.9,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142374724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineering novel adeno-associated viruses (AAVs) for improved delivery in the nervous system 设计新型腺相关病毒 (AAV),改进在神经系统中的传输。
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-09-28 DOI: 10.1016/j.cbpa.2024.102532
Ana D. Carneiro , David V. Schaffer
Harnessing adeno-associated virus (AAV) vectors for therapeutic gene delivery has emerged as a progressively promising strategy to treat disorders of both the central nervous system (CNS) and peripheral nervous system (PNS), and there are many ongoing clinical trials. However, unique physiological and molecular characteristics of the CNS and PNS pose obstacles to efficient vector delivery, ranging from the blood-brain barrier to the diverse nature of nervous system disorders. Engineering novel AAV capsids may help overcome these ongoing challenges and maximize therapeutic transgene delivery. This article discusses strategies for innovative AAV capsid development, highlighting recent advances. Notably, advances in next generation sequencing and machine learning have sparked new approaches for capsid investigation and engineering. Furthermore, we outline future directions and additional challenges in AAV-mediated gene therapy in the CNS and PNS.
利用腺相关病毒(AAV)载体进行治疗性基因递送已逐渐成为治疗中枢神经系统(CNS)和周围神经系统(PNS)疾病的一种有前途的策略,目前有许多临床试验正在进行中。然而,从血脑屏障到神经系统疾病的多样性,中枢神经系统和外周神经系统独特的生理和分子特征给载体的高效传递造成了障碍。设计新型 AAV 外壳可能有助于克服这些持续存在的挑战,并最大限度地提高治疗性转基因递送。本文讨论了创新 AAV 病毒衣壳的开发策略,并重点介绍了最近取得的进展。值得注意的是,下一代测序和机器学习的进步为噬菌体研究和工程设计带来了新方法。此外,我们还概述了 AAV 介导的中枢神经系统和前枢神经系统基因治疗的未来方向和其他挑战。
{"title":"Engineering novel adeno-associated viruses (AAVs) for improved delivery in the nervous system","authors":"Ana D. Carneiro ,&nbsp;David V. Schaffer","doi":"10.1016/j.cbpa.2024.102532","DOIUrl":"10.1016/j.cbpa.2024.102532","url":null,"abstract":"<div><div>Harnessing adeno-associated virus (AAV) vectors for therapeutic gene delivery has emerged as a progressively promising strategy to treat disorders of both the central nervous system (CNS) and peripheral nervous system (PNS), and there are many ongoing clinical trials. However, unique physiological and molecular characteristics of the CNS and PNS pose obstacles to efficient vector delivery, ranging from the blood-brain barrier to the diverse nature of nervous system disorders. Engineering novel AAV capsids may help overcome these ongoing challenges and maximize therapeutic transgene delivery. This article discusses strategies for innovative AAV capsid development, highlighting recent advances. Notably, advances in next generation sequencing and machine learning have sparked new approaches for capsid investigation and engineering. Furthermore, we outline future directions and additional challenges in AAV-mediated gene therapy in the CNS and PNS.</div></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"83 ","pages":"Article 102532"},"PeriodicalIF":6.9,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142338142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic synthetic anion transporters 治疗用合成阴离子转运体
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-09-27 DOI: 10.1016/j.cbpa.2024.102535
Elba Feo, Philip A. Gale
This short review highlights recent examples of small-molecule anion transporters reported in the literature that have potentially useful biological activity. This includes anionophores with antibiotic or antifungal activity, anticancer activity, or the potential to treat channelopathies such as cystic fibrosis. Additionally selective and targeted anion transporters are also discussed.
这篇简短的综述重点介绍了文献中报道的具有潜在生物活性的小分子阴离子转运体的最新实例。其中包括具有抗生素或抗真菌活性、抗癌活性或治疗囊性纤维化等通道病的潜力的阴离子载体。此外,还讨论了选择性和靶向性阴离子转运体。
{"title":"Therapeutic synthetic anion transporters","authors":"Elba Feo,&nbsp;Philip A. Gale","doi":"10.1016/j.cbpa.2024.102535","DOIUrl":"10.1016/j.cbpa.2024.102535","url":null,"abstract":"<div><div>This short review highlights recent examples of small-molecule anion transporters reported in the literature that have potentially useful biological activity. This includes anionophores with antibiotic or antifungal activity, anticancer activity, or the potential to treat channelopathies such as cystic fibrosis. Additionally selective and targeted anion transporters are also discussed.</div></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"83 ","pages":"Article 102535"},"PeriodicalIF":6.9,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142327711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endogenous electrophiles and peroxymonocarbonate can link tyrosine phosphorylation cascades with the cytosolic TXNRD1 selenoprotein and the KEAP1/NRF2 system 内源性亲电子物和过氧碳酸氢盐可将酪氨酸磷酸化级联与细胞质 TXNRD1 硒蛋白和 KEAP1/NRF2 系统联系起来。
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-09-06 DOI: 10.1016/j.cbpa.2024.102522
Markus Dagnell , Elias S.J. Arnér

Endogenously formed reactive molecules, such as lipid peroxides, 4-hydroxynonenal, methylglyoxal and other reactive oxygen species, can have major effects on cells. Accumulation of these molecules is counteracted by antioxidant enzymes, including the glutathione (GSH) and thioredoxin (Trx) systems, in turn regulated by the KEAP1/NRF2 system. Receptor tyrosine kinases (RTK) and their counteracting protein tyrosine phosphatases (PTP) are also modulated through redox regulation of PTP activities. The cytosolic selenoprotein thioredoxin reductase (TXNRD1) is particularly prone to attack at its easily accessible catalytic selenocysteine (Sec) residue by reactive electrophilic compounds. Therefore, we here discuss how endogenously formed electrophiles can modulate RTK/PTP signaling in a concentration- and time dependent manner by reactions either directly or indirectly linking TXNRD1 with the KEAP1/NRF2 system. Moreover, recent findings suggest that endogenous formation of peroxymonocarbonate can efficiently inhibit PTP activities and stimulate RTK signaling, seemingly bypassing PTP reduction as otherwise supported by the GSH/Trx systems.

内源性形成的活性分子,如脂质过氧化物、4-羟基壬烯醛、甲基乙二醛和其他活性氧,可对细胞产生重大影响。包括谷胱甘肽(GSH)和硫氧还蛋白(Trx)系统在内的抗氧化酶可抵消这些分子的积累,而这些抗氧化酶又受 KEAP1/NRF2 系统的调节。受体酪氨酸激酶(RTK)及其抗衡蛋白酪氨酸磷酸酶(PTP)也通过氧化还原作用调节 PTP 活性。细胞硒蛋白硫代氧化还原酶(TXNRD1)的催化硒半胱氨酸(Sec)残基很容易受到亲电化合物的攻击。因此,我们在此讨论内源性亲电化合物如何通过直接或间接连接 TXNRD1 与 KEAP1/NRF2 系统的反应,以浓度和时间依赖性的方式调节 RTK/PTP 信号转导。此外,最近的研究结果表明,内源性形成的过一碳酸酯可有效抑制 PTP 活性并刺激 RTK 信号传导,这似乎绕过了 PTP 还原过程,而 GSH/Trx 系统也支持这一点。
{"title":"Endogenous electrophiles and peroxymonocarbonate can link tyrosine phosphorylation cascades with the cytosolic TXNRD1 selenoprotein and the KEAP1/NRF2 system","authors":"Markus Dagnell ,&nbsp;Elias S.J. Arnér","doi":"10.1016/j.cbpa.2024.102522","DOIUrl":"10.1016/j.cbpa.2024.102522","url":null,"abstract":"<div><p>Endogenously formed reactive molecules, such as lipid peroxides, 4-hydroxynonenal, methylglyoxal and other reactive oxygen species, can have major effects on cells. Accumulation of these molecules is counteracted by antioxidant enzymes, including the glutathione (GSH) and thioredoxin (Trx) systems, in turn regulated by the KEAP1/NRF2 system. Receptor tyrosine kinases (RTK) and their counteracting protein tyrosine phosphatases (PTP) are also modulated through redox regulation of PTP activities. The cytosolic selenoprotein thioredoxin reductase (TXNRD1) is particularly prone to attack at its easily accessible catalytic selenocysteine (Sec) residue by reactive electrophilic compounds. Therefore, we here discuss how endogenously formed electrophiles can modulate RTK/PTP signaling in a concentration- and time dependent manner by reactions either directly or indirectly linking TXNRD1 with the KEAP1/NRF2 system. Moreover, recent findings suggest that endogenous formation of peroxymonocarbonate can efficiently inhibit PTP activities and stimulate RTK signaling, seemingly bypassing PTP reduction as otherwise supported by the GSH/Trx systems.</p></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"83 ","pages":"Article 102522"},"PeriodicalIF":6.9,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S136759312400098X/pdfft?md5=a310db9e055eef46580e7b9e5c96a3b4&pid=1-s2.0-S136759312400098X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142144529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An expanded molecular and systems toolbox for imaging, mapping, and controlling local translation 用于成像、绘图和控制局部翻译的扩展分子和系统工具箱
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-09-02 DOI: 10.1016/j.cbpa.2024.102523
Warunya Onchan , Chadaporn Attakitbancha , Chayasith Uttamapinant

Localized protein translation occurs through trafficking of mRNAs and protein translation machineries to different compartments of the cell, leading to rapid on-site synthesis of proteins in response to signaling cues. The spatiotemporally precise nature of the local translation process necessitates continual developments of technologies reviewed herein to visualize and map biomolecular components and the translation process with better spatial and temporal resolution and with fewer artifacts. We also discuss approaches to control local translation, which can serve as a design paradigm for subcellular genetic devices for eukaryotic synthetic biology.

局部蛋白质翻译是通过将 mRNA 和蛋白质翻译机制转移到细胞的不同区室,从而在现场快速合成蛋白质,以响应信号提示。由于局部翻译过程具有精确的时空性质,因此有必要不断开发本文所讨论的技术,以便以更高的时空分辨率和更少的伪影对生物分子成分和翻译过程进行可视化和绘图。我们还讨论了控制局部翻译的方法,这可以作为真核合成生物学亚细胞遗传设备的设计范例。
{"title":"An expanded molecular and systems toolbox for imaging, mapping, and controlling local translation","authors":"Warunya Onchan ,&nbsp;Chadaporn Attakitbancha ,&nbsp;Chayasith Uttamapinant","doi":"10.1016/j.cbpa.2024.102523","DOIUrl":"10.1016/j.cbpa.2024.102523","url":null,"abstract":"<div><p>Localized protein translation occurs through trafficking of mRNAs and protein translation machineries to different compartments of the cell, leading to rapid on-site synthesis of proteins in response to signaling cues. The spatiotemporally precise nature of the local translation process necessitates continual developments of technologies reviewed herein to visualize and map biomolecular components and the translation process with better spatial and temporal resolution and with fewer artifacts. We also discuss approaches to control local translation, which can serve as a design paradigm for subcellular genetic devices for eukaryotic synthetic biology.</p></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"82 ","pages":"Article 102523"},"PeriodicalIF":6.9,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142122979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myeloid C-type lectin receptors in host–pathogen interactions and glycan-based targeting 髓系 C 型凝集素受体在宿主-病原体相互作用和基于聚糖的靶向中的作用
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-08-29 DOI: 10.1016/j.cbpa.2024.102521
Felix Stegmann , Bernd Lepenies

Lectin–glycan interactions play a crucial role in the immune system. An important class of lectins in the innate immune system is myeloid C-type lectin receptors (CLRs). Myeloid CLRs act as pattern recognition receptors and are predominantly expressed by myeloid cells, such as macrophages, dendritic cells, and neutrophils. In innate immunity, CLRs contribute to self/non-self discrimination. While the recognition of pathogen-associated molecular patterns (PAMPs) by CLRs may contribute to a protective immune response, CLR engagement can also be exploited by pathogens for immune evasion. Since various CLRs act as endocytic receptors and trigger distinct signaling pathways in myeloid cells, CLR targeting has proven useful for drug/antigen delivery into antigen-presenting cells and the modulation of immune responses. This review covers recent discoveries of pathogen/CLR interactions and novel approaches for CLR targeting within the period of the past two years.

凝集素与糖的相互作用在免疫系统中起着至关重要的作用。髓系 C 型凝集素受体(CLR)是先天性免疫系统中的一类重要凝集素。髓系 C 型凝集素受体是一种模式识别受体,主要由髓系细胞(如巨噬细胞、树突状细胞和中性粒细胞)表达。在先天性免疫中,CLRs 有助于自我/非自我识别。虽然 CLRs 识别病原体相关分子模式(PAMPs)可能有助于保护性免疫反应,但病原体也可能利用 CLRs 参与免疫逃避。由于各种 CLR 可作为内细胞受体并触发髓系细胞中不同的信号通路,因此 CLR 靶向已被证明可用于将药物/抗原递送至抗原递呈细胞并调节免疫反应。本综述涵盖了过去两年中病原体/CLR相互作用的最新发现以及CLR靶向的新方法。
{"title":"Myeloid C-type lectin receptors in host–pathogen interactions and glycan-based targeting","authors":"Felix Stegmann ,&nbsp;Bernd Lepenies","doi":"10.1016/j.cbpa.2024.102521","DOIUrl":"10.1016/j.cbpa.2024.102521","url":null,"abstract":"<div><p>Lectin–glycan interactions play a crucial role in the immune system. An important class of lectins in the innate immune system is myeloid C-type lectin receptors (CLRs). Myeloid CLRs act as pattern recognition receptors and are predominantly expressed by myeloid cells, such as macrophages, dendritic cells, and neutrophils. In innate immunity, CLRs contribute to self/non-self discrimination. While the recognition of pathogen-associated molecular patterns (PAMPs) by CLRs may contribute to a protective immune response, CLR engagement can also be exploited by pathogens for immune evasion. Since various CLRs act as endocytic receptors and trigger distinct signaling pathways in myeloid cells, CLR targeting has proven useful for drug/antigen delivery into antigen-presenting cells and the modulation of immune responses. This review covers recent discoveries of pathogen/CLR interactions and novel approaches for CLR targeting within the period of the past two years.</p></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"82 ","pages":"Article 102521"},"PeriodicalIF":6.9,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1367593124000978/pdfft?md5=306dced818d81a5ca24ab6335f230013&pid=1-s2.0-S1367593124000978-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142099058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroprotective signaling by hydrogen sulfide and its dysregulation in Alzheimer's disease 硫化氢的神经保护信号及其在阿尔茨海默病中的失调
IF 6.9 2区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-08-13 DOI: 10.1016/j.cbpa.2024.102511
Bindu D. Paul , Andrew A. Pieper

The ancient messenger molecule hydrogen sulfide (H2S) modulates myriad signaling cascades and has been conserved across evolutionary boundaries. Although traditionally known as an environmental toxin, H2S is also synthesized endogenously to exert modulatory and homeostatic effects in a broad array of physiologic functions. Notably, H2S levels are tightly physiologically regulated, as both its excess and paucity can be toxic. Accumulating evidence has revealed pivotal roles for H2S in neuroprotection and normal cognitive function, and H2S homeostasis is dysregulated in neurodegenerative conditions. Here, we review the normal neuroprotective roles of H2S that go awry in Alzheimer's disease, the most common form of neurodegenerative disease.

古老的信使分子硫化氢(H2S)能调节无数的信号级联,并在进化过程中保持不变。虽然 H2S 传统上被认为是一种环境毒素,但它也可以在内源性合成,在一系列生理功能中发挥调节和平衡作用。值得注意的是,H2S 的水平受到严格的生理调控,因为过量或过少都会产生毒性。越来越多的证据表明,H2S 在神经保护和正常认知功能中发挥着关键作用,而在神经退行性疾病中,H2S 的平衡则会失调。在此,我们回顾了 H2S 在阿尔茨海默病(最常见的神经退行性疾病)中发挥的正常神经保护作用。
{"title":"Neuroprotective signaling by hydrogen sulfide and its dysregulation in Alzheimer's disease","authors":"Bindu D. Paul ,&nbsp;Andrew A. Pieper","doi":"10.1016/j.cbpa.2024.102511","DOIUrl":"10.1016/j.cbpa.2024.102511","url":null,"abstract":"<div><p>The ancient messenger molecule hydrogen sulfide (H<sub>2</sub>S) modulates myriad signaling cascades and has been conserved across evolutionary boundaries. Although traditionally known as an environmental toxin, H<sub>2</sub>S is also synthesized endogenously to exert modulatory and homeostatic effects in a broad array of physiologic functions. Notably, H<sub>2</sub>S levels are tightly physiologically regulated, as both its excess and paucity can be toxic. Accumulating evidence has revealed pivotal roles for H<sub>2</sub>S in neuroprotection and normal cognitive function, and H<sub>2</sub>S homeostasis is dysregulated in neurodegenerative conditions. Here, we review the normal neuroprotective roles of H<sub>2</sub>S that go awry in Alzheimer's disease, the most common form of neurodegenerative disease.</p></div>","PeriodicalId":291,"journal":{"name":"Current Opinion in Chemical Biology","volume":"82 ","pages":"Article 102511"},"PeriodicalIF":6.9,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1367593124000875/pdfft?md5=e3e84ee89762b9b7024bc906392dbab2&pid=1-s2.0-S1367593124000875-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141978218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Chemical Biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1